mRNA-1273

Moderna Covid-19 Vaccine Confers At Least 3 Months Immunity: Study

The Moderna Covid19 Vaccine, which recently confirmed to have 94 per cent efficacy, causes the human immune system to produce effective antibodies that endure for at least three months, according…

View Post

Experimental COVID-19 Vaccine Safe, Generates Immune Response

New Delhi: An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy…

View Post

Moderna COVID-19 Vaccine Can Produce Immune Response Against Coronavirus: Study

New Delhi: An experimental COVID-19 vaccine developed by the American biotech company Moderna prompted neutralising antibody activity in healthy adults, though it led to minor side effects in many patients,…

View Post

US Firm Leads COVID-19 Vaccine Race

New Delhi: As scientists across the world work frantically to find a vaccine against COVID-19, which continues its rapid global spread, all eyes are on US-based company Moderna’s encouraging early…

View Post

Menu

mRNA-1273

Moderna Covid-19 Vaccine Confers At Least 3 Months Immunity: Study

Experimental COVID-19 Vaccine Safe, Generates Immune Response

Moderna COVID-19 Vaccine Can Produce Immune Response Against Coronavirus: Study

US Firm Leads COVID-19 Vaccine Race

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial